Social media

How do you choose the right control group for organ impairment trials? Despite consensus on the need for demographic similarity between test and control groups, practical guidance is surprisingly scarce. Too often, sele...

The number of clinical trials using digital endpoints has doubled every 3 years since 2015. The industry is seeing that leveraging DHTs in trials offers: - Faster data collection - Greater sensitivity to treatment effec...

Risk-based strategies aren’t optional, they’re essential. ICON’s Victoria DeVeaugh-Geiss shares six principles sponsors should consider building into their clinical trial operations. Read the blog https://ow.ly/i5kG50Xok...

Did you know LinkedIn has a feature that allows you to privately express your interest in working with ICON? By clicking the 'I'm interested' button on our company page, you can signal to our Talent Acquisition team tha...

Regulators, patients, and sponsors are all asking: Does this treatment improve life beyond the numbers? And in obesity trials, the number on the scale is only a portion of what patients care about. Learn more about wh...

This World Diabetes Day, the theme ‘Diabetes and the workplace’ reminds us that 70% of people living with diabetes are of working age. At ICON, we recognise the urgency of advancing therapies that improve outcomes for t...

By 2050, the number of people living with diabetes is projected to rise to 853 million. In the past 5 years, ICON has conducted 198 metabolic studies involving 50,000+ patients and healthy volunteers at 8,600+ sites, inc...

Flexible, risk-based monitoring strategies are transforming global trial delivery. ICON’s new whitepaper shows how smarter oversight improves quality, reduces cost and accelerates timelines. Download now: https://www.ico...

Early clinical trial designs—especially first-in-human (FIH) studies—are increasingly tailored to the unique needs of specific therapeutic areas. In neurodegenerative diseases, there is a growing shift toward flexible an...

Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory su...

In the dynamic world of life sciences, the consultancy sector is undergoing a transformation as cost pressures increase, speed to market needs accelerate and technology permeates every aspect. Against this backdrop, clie...

Use Journals & Congresses to sort over 10,000 journals and congresses by submission date and lead times. Get your answer quickly so you can focus on your work. See how easy it is for yourself & request a demo. https://ow...